{"disease":{"id":"her2-expression-and-clinical-pathological-characteristics-in-prostate-cancer","name":"her2 expression and clinical pathological characteristics in prostate cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06146114","title":"Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}